Compare CCEL & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | RMCO |
|---|---|---|
| Founded | 1989 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 35.3M |
| IPO Year | 2022 | N/A |
| Metric | CCEL | RMCO |
|---|---|---|
| Price | $3.63 | $2.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.4K | ★ 35.7K |
| Earning Date | 04-14-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.26% | 0.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $25,384,279.00 | N/A |
| Revenue This Year | N/A | $209.10 |
| Revenue Next Year | N/A | $133.33 |
| P/E Ratio | $363.15 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $1.12 |
| 52 Week High | $5.43 | $5.00 |
| Indicator | CCEL | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 52.25 |
| Support Level | $3.14 | $2.17 |
| Resistance Level | $3.64 | $3.06 |
| Average True Range (ATR) | 0.19 | 0.26 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 61.69 | 60.00 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.